ReviewDrug design, development and therapy2022

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP.

Lijing WangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.